Autopsy report · NCT03946033

Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon Cancer

“Canceled by Immunoscore's manufacturer”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

UNICANCER

Sponsor type

University, hospital or other

Conditions

Colonic Neoplasms

Interventions

Immunoscore Colon Test

Participants

0

Sites

21

Countries

France

Trials that died the same way

• Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
  “Vaccine manufacturing has been suspended” (61% match in meaning)
• An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis
  “Protocol was cancelled by company based on overall efficacy, no safety concern” (59% match in meaning)
• The Study for Evaluate of Satety and Dfficacy of Hemostatic Device
  “The company stopped manufacturing the product” (56% match in meaning)
• Investigating iLux Efficacy in Contact Lens Wearers With Evaporative Dry Eye Disease
  “Cancelled due to COVID-19” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.